Abstract:WHAT IS KNOWN AND OBJECTIVE:Drug-drug interactions (DDI) are frequent causes of adverse clinical drug reactions. Efforts have been directed at the early stage to achieve accurate identification of DDI for drug safety assessments, including the development of in silico predictive methods. In particular, similarity-based in silico methods have been developed to assess DDI with good accuracies, and machine learning methods have been employed to further extend the predictive range of similarity-based approaches. However, the performance of a developed machine learning method is lower than expectations partly because of the use of less diverse DDI training data sets and a less optimal set of similarity measures.METHOD:In this work, we developed a machine learning model using support vector machines (SVMs) based on the literature-reported established set of similarity measures and comprehensive training data sets. The established similarity measures include the 2D molecular structure similarity, 3D pharmacophoric similarity, interaction profile fingerprint (IPF) similarity, target similarity and adverse drug effect (ADE) similarity, which were extracted from well-known databases, such as DrugBank and Side Effect Resource (SIDER). A pairwise kernel was constructed for the known and possible drug pairs based on the five established similarity measures and then used as the input vector of the SVM.RESULT:The 10-fold cross-validation studies showed a predictive performance of AUROC >0.97, which is significantly improved compared with the AUROC of 0.67 of an analogously developed machine learning model. Our study suggested that a similarity-based SVM prediction is highly useful for identifying DDI.CONCLUSION:in silico methods based on multifarious drug similarities have been suggested to be feasible for DDI prediction in various studies. In this way, our pairwise kernel SVM model had better accuracies than some previous works, which can be used as a pharmacovigilance tool to detect potential DDI.

Identification of Anticancer and Anti-inflammatory Drugs from Drug-target Interaction Descriptors by Machine Learning..

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

Identification of Drug-Target Interactions Via Multiple Information Integration.

Improved Prediction Of Drug-Target Interactions Based On Ensemble Learning With Fuzzy Local Ternary Pattern

Predicting Drug-Target Interactions Between New Drugs and New Targets via Pairwise K-nearest Neighbor and Automatic Similarity Selection.

Predicting Drug-Target Interaction for New Drugs Using Enhanced Similarity Measures and Super-Target Clustering.

Recent Advances in the Machine Learning-Based Drug-Target Interaction Prediction

In Silico Drug Repositioning Using Deep Learning and Comprehensive Similarity Measures

A Machine Learning-Based Biological Drug–Target Interaction Prediction Method for a Tripartite Heterogeneous Network

Application of Machine Learning for Drug–Target Interaction Prediction

A Systematic Prediction Of Multiple Drug-Target Interactions From Chemical, Genomic, And Pharmacological Data

Drug-target Interaction Prediction: Databases, Web Servers and Computational Models.

Similarity-Based Integrated Method For Predicting Drug-Disease Interactions

Similarity-based Machine Learning Support Vector Machine Predictor of Drug-Drug Interactions with Improved Accuracies

The Computational Models of Drug-target Interaction Prediction

A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm

Drug Repositioning By Kernel-Based Integration Of Molecular Structure, Molecular Activity, And Phenotype Data

Predicting Associations among Drugs, Targets and Diseases by Tensor Decomposition for Drug Repositioning

Machine learning for drug repositioning: Recent advances and challenges

Drug-Target Interaction Prediction Based On Drug Fingerprint Information And Protein Sequence

Attention-based approach to predict drug-target interactions across seven target superfamilies